GlassScriptPhysician profile
Alice Costen
NPI 1629047543
$1,826.91
in general payments reported to CMS, 2019-2025
11 companies · $734 in 2025
The $734 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $117 · 2024: $976 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Travel and Lodging: $316 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.00 |
| Travel and Lodging | $315.91 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $597.86 | 2024-2025 | Belbuca |
| Medtronic, INC. | $584.34 | 2024 | Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.12 | 2025 | Relistor |
| Valinor Pharma, LLC | $115.56 | 2024-2025 | Movantik |
| Virtus Pharmaceuticals LLC | $104.19 | 2024-2025 | Levorphanol Tartrate |
| Scilex Pharmaceuticals INC. | $97.79 | 2023-2025 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $59.84 | 2024-2025 | |
| Curonix LLC | $29.64 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $24.91 | 2023 | Sprint Pns System |
| Averitas Pharma INC. | $24.11 | 2023 | Qutenza |
| Forte Bio-Pharma LLC | $22.55 | 2025 | Prolate, Tanlor, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Costen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.